Hinge Health officer plans $5.1M stock sale

Officer James Budge filed a Rule 144 notice to sell 55,561 Hinge Health common shares valued at about $5.07 million.

Available on EDGAR 09/10/2026 - 04:45 PM EDT Accepted by SEC EDGAR 09/10/2026 - 04:44 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Hinge Health, Inc. (HNGE) received a notice that officer James Budge intends to sell 55,561 shares of common stock under Rule 144 through Morgan Stanley Smith Barney LLC on or after September 10, 2026. The shares were acquired upon vesting of restricted stock units between May 21, 2025 and September 1, 2026.

The planned sale has an indicated aggregate market value of $5,073,274.91. Hinge Health, Inc. reports that 62,468,721 shares of common stock are outstanding, providing context for the size of the proposed Rule 144 transaction.

Key Figures

Shares to be sold: 55,561 shares Aggregate market value of securities to be sold: $5,073,274.91 Shares outstanding: 62,468,721 shares +2 more

5 metrics

Shares to be sold 55,561 shares Common stock proposed to be sold under Rule 144

Aggregate market value of securities to be sold $5,073,274.91 Value associated with the 55,561 Hinge Health common shares

Shares outstanding 62,468,721 shares Hinge Health, Inc. common stock outstanding

Acquisition period for RSU shares May 21, 2025 – September 1, 2026 Period in which RSUs vested to yield the shares

Planned sale date September 10, 2026 Approximate date of sale for the securities to be sold

Key Terms

Rule 144, restricted stock units, aggregate market value

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock units financial

"The securities to be sold were acquired upon the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

aggregate market value financial

"55561 | 5073274.91 | 62468721"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for HNGE?

It discloses that officer James Budge plans to sell 55,561 shares of Hinge Health, Inc. common stock under Rule 144 through Morgan Stanley Smith Barney LLC, with an indicated aggregate market value of $5,073,274.91, starting on or after September 10, 2026.

How many Hinge Health (HNGE) shares are covered by this planned Rule 144 sale?

The notice covers a planned sale of 55,561 shares of common stock of Hinge Health, Inc. These shares were acquired upon the vesting of restricted stock units during the period from May 21, 2025 through September 1, 2026.

What is the approximate value of the HNGE shares in James Budge’s planned sale?

The filing lists an aggregate market value of $5,073,274.91 for the 55,561 shares of Hinge Health, Inc. common stock that are proposed to be sold under Rule 144.

How many Hinge Health (HNGE) shares are outstanding according to this notice?

The notice states that Hinge Health, Inc. has 62,468,721 shares of common stock outstanding, giving context for the relative size of the 55,561-share planned Rule 144 sale.

What is the origin of the HNGE shares that James Budge plans to sell?

The shares were acquired from Hinge Health, Inc. upon the vesting of restricted stock units, with vesting occurring during the period from May 21, 2025 through September 1, 2026, as stated in the remarks section.

Which broker is named for executing the planned HNGE sale?

The Form 144 names Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza, New York, as the broker handling the planned Rule 144 sale of Hinge Health, Inc. common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001338176
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	455 Market Street, Suite 700 San Francisco CALIFORNIA 94105
Phone	4157262206
Name of Person for Whose Account the Securities are To Be Sold	JAMES BUDGE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	55561	5073274.91	62468721	09/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/21/2025	Restricted Stock Units	Issuer			55561	05/21/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 05/21/2025 through 09/01/2026.
Date of Notice	09/10/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ James Budge
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)